---
title: "INVO Fertility | 8-K: FY2025 Q2 Revenue: USD 1.864 M"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/253256981.md"
published_at: "2025-08-15T18:04:23.000Z"
---

# INVO Fertility | 8-K: FY2025 Q2 Revenue: USD 1.864 M

Revenue: As of FY2025 Q2, the actual value is USD 1.864 M.

EPS: As of FY2025 Q2, the actual value is USD -13.3.

### Revenue

-   Total revenue for Q2 2025 was $1,863,654, marking a 1% increase from $1,836,597 in Q2 2024, setting a new quarterly record for the company.
-   Consolidated clinic revenue from the INVO Center in Atlanta, Georgia, and the fertility clinic in Madison, Wisconsin, increased by 1% to $1,832,094 from $1,807,921.
-   Revenue from all clinics, including both consolidated and equity method clinics, was $2,188,893, a 2% increase from $2,141,229.

### Operational Metrics

-   Net loss from continuing operations was - $3.2 million, compared to - $2.2 million in the previous year.
-   Adjusted EBITDA was - $587,230, compared to - $509,623 in the prior year.
-   Total operating expenses increased to $4,853,742 from $3,689,510 in Q2 2024.
-   Loss from operations was - $2,990,088, compared to - $1,852,913 in Q2 2024.

### Cash Flow

-   The report does not provide specific figures for operating cash flow or free cash flow.

### Unique Metrics

-   The company completed the divestiture of NAYA Therapeutics, Inc., retaining a minority position to potentially benefit from NAYA’s ongoing clinical development.

### Outlook / Guidance

-   The company is focused on maintaining a highly efficient and scalable operating structure while integrating complementary and accretive revenue-generating businesses and technologies.

### Related Stocks

- [IVF.US - INVO Fertility](https://longbridge.com/en/quote/IVF.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| INVO Fertility Inc. Granted U.S. Patent for Modified INVOcell® Fertility Device | INVO Fertility Inc. has been granted a U.S. patent for a modified version of its INVOcell® fertility device (U.S. Patent | [Link](https://longbridge.com/en/news/275612613.md) |
| Nvidia's new Meta deal may not be great news for these other tech stocks | Nvidia's expanded partnership with Meta has negatively impacted shares of competitors like Broadcom, AMD, and Arista. Me | [Link](https://longbridge.com/en/news/276186338.md) |
| Robinhood to Launch Private Markets Fund for Retail Investors – These Are Its Holdings | Robinhood has launched Robinhood Ventures Fund I, its first closed-end fund, set to trade on the NYSE under the ticker R | [Link](https://longbridge.com/en/news/276167795.md) |
| Western Digital to sell $3.17 billion stake in Sandisk | Feb 18 (Reuters) - Flash memory maker Sandiskon Wednesday said that Western Digitalwill sell a stake worth $3.17 billion | [Link](https://longbridge.com/en/news/276201046.md) |
| Viking Global Dissolves Share Stake In Nike,Meta Platforms,Philip Morris | Viking Global has dissolved its share stakes in Nike, Meta Platforms, and Philip Morris, according to SEC filings. The f | [Link](https://longbridge.com/en/news/276178311.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.